In contrast, NASH pathogenesis was suppressed in mice with a SPARCL1 deficiency or SPARCL1 silencing in white AT as well as in those treated with a SPARCL1 neutralizing antibody. The gene discussed is SPARCL1; the disease is metabolic dysfunction-associated steatohepatitis.